<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Durbin</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>McArthur</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Marron</surname>
    <given-names>J. A.</given-names>
   </name>
   <name>
    <surname>Blaney</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Thumar</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Wanionek</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2006</year>). 
  <article-title>rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults.</article-title>
  <source>
   <italic>Hum. Vaccin</italic>
  </source>
  <volume>2</volume>
  <fpage>255</fpage>â€“
  <lpage>260</lpage>. 
  <pub-id pub-id-type="doi">10.4161/hv.2.6.3494</pub-id>
  <?supplied-pmid 17106267?>
  <pub-id pub-id-type="pmid">17106267</pub-id>
 </mixed-citation>
</ref>
